Sg3 Management, LLC Dynavax Technologies Corp Put Options Transaction History

Sg3 Management, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 15, 2022	SELL	$13.17 - $20.94 $197,550 - $314,100	-15,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.16 - $19.83 $137,400 - $297,450	15,000 New	15,000 $288,000
Q2 2017 Jan 25, 2018	SELL	N/A	-6,000 Closed	0 $0
Q1 2017 Feb 26, 2018	BUY	N/A	5,940 Added 9900.0%	6,000 $36,000
Q1 2017 Jan 25, 2018	SELL	N/A	-5,940 Reduced 99.0%	60 $24,000
Q4 2016 Feb 23, 2018	BUY	N/A	5,940 Added 9900.0%	6,000 $24,000
Q4 2016 Jan 24, 2018	BUY	N/A	60	60 $37,000

276

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.63B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.